- Home
- CMU vs VERU Comparison
CMU vs VERU Comparison
Compare CMU & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMU
- VERU
- Stock Information
- Founded
- CMU 1987
- VERU 1971
- Country
- CMU United States
- VERU United States
- Employees
- CMU N/A
- VERU N/A
- Industry
- CMU Investment Managers
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- CMU Finance
- VERU Health Care
- Exchange
- CMU Nasdaq
- VERU Nasdaq
- Market Cap
- CMU 90.7M
- VERU 76.9M
- IPO Year
- CMU N/A
- VERU 1990
- Fundamental
- Price
- CMU $3.35
- VERU $0.55
- Analyst Decision
- CMU
- VERU Strong Buy
- Analyst Count
- CMU 0
- VERU 2
- Target Price
- CMU N/A
- VERU $4.00
- AVG Volume (30 Days)
- CMU 82.4K
- VERU 3.3M
- Earning Date
- CMU 01-01-0001
- VERU 05-08-2025
- Dividend Yield
- CMU 4.08%
- VERU N/A
- EPS Growth
- CMU N/A
- VERU N/A
- EPS
- CMU 0.07
- VERU N/A
- Revenue
- CMU N/A
- VERU $16,886,419.00
- Revenue This Year
- CMU N/A
- VERU N/A
- Revenue Next Year
- CMU N/A
- VERU N/A
- P/E Ratio
- CMU $47.57
- VERU N/A
- Revenue Growth
- CMU N/A
- VERU 134.43
- 52 Week Low
- CMU $2.78
- VERU $0.45
- 52 Week High
- CMU $3.38
- VERU $1.42
- Technical
- Relative Strength Index (RSI)
- CMU 44.80
- VERU 53.36
- Support Level
- CMU $3.34
- VERU $0.48
- Resistance Level
- CMU $3.39
- VERU $0.67
- Average True Range (ATR)
- CMU 0.03
- VERU 0.04
- MACD
- CMU -0.00
- VERU 0.00
- Stochastic Oscillator
- CMU 31.75
- VERU 25.37
About CMU MFS Municipal Income Trust
Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.